Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	81,983	93,403	77,057	66,029	50,990	41,049
Market Cap Growth	30.12%	21.21%	16.70%	29.49%	24.22%	1.64%
Enterprise Value	66,400	80,414	66,767	57,309	47,783	35,796
Last Close Price	762.00	878.29	721.49	631.52	483.11	375.48
PE Ratio	18.85	25.26	18.88	8.77	15.83	20.34
Forward PE	16.08	19.36	17.29	11.00	14.28	13.81
PS Ratio	5.92	7.12	6.33	4.11	6.00	6.26
PB Ratio	2.80	3.60	3.40	3.52	4.62	3.70
P/TBV Ratio	4.02	3.75	3.54	3.52	4.62	3.70
P/FCF Ratio	23.83	24.10	17.41	10.11	25.45	20.52
P/OCF Ratio	19.30	20.33	15.37	9.32	19.48	16.89
PEG Ratio	0.97	4.75	-	-	1.55	1.26
EV/Sales Ratio	4.80	6.13	5.48	3.57	5.62	5.46
EV/EBITDA Ratio	14.44	17.28	12.51	6.17	12.25	14.79
EV/EBIT Ratio	16.08	19.00	13.37	6.37	13.04	16.20
EV/FCF Ratio	19.30	20.75	15.09	8.78	23.85	17.89
Debt / Equity Ratio	0.09	0.11	0.12	0.14	0.24	0.06
Debt / EBITDA Ratio	0.59	0.60	0.52	0.29	0.69	0.29
Debt / FCF Ratio	0.79	0.72	0.63	0.41	1.35	0.36
Asset Turnover	0.40	0.42	0.45	0.75	0.53	0.49
Inventory Turnover	2.44	2.51	2.37	2.74	2.26	2.51
Quick Ratio	4.34	4.82	4.16	2.98	2.86	2.86
Current Ratio	5.28	5.69	5.06	3.56	3.63	3.67
Return on Equity (ROE)	17.17%	16.26%	20.94%	54.21%	31.77%	21.32%
Return on Assets (ROA)	7.41%	8.49%	11.42%	26.39%	14.33%	10.41%
Return on Capital (ROIC)	8.65%	9.76%	13.31%	31.95%	17.95%	12.99%
Earnings Yield	5.68%	4.23%	5.63%	12.23%	6.89%	5.15%
FCF Yield	4.20%	4.15%	5.74%	9.89%	3.93%	4.87%
Buyback Yield / Dilution	-1.16%	-0.18%	-1.16%	2.52%	-0.44%	0.17%
Total Shareholder Return	-1.16%	-0.18%	-1.16%	2.52%	-0.44%	0.17%

Source: S&P Capital IQ. Standard template. Financial Sources.